MDT 70.81 Medtronic Inc $MDT Hit a 52 week high of 70.95

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
MDT 70.81 Medtronic Inc $MDT Hit a 52 week high of 70.95 Closing the day 09:45 at 70.81 +1.62 +2.34% With a day low of 68.83 and a total volume of 1,626,700.

MDT Recent Posts: http://investorshangout.com/Medtronic-Inc-MDT-51763/

MDT Medtronic Inc Recent Headline News

See Why Medtronic Stock Is Surging Today
Sure Dividend - at Seeking Alpha - 16 mins ago

MDT: 71.79 (+2.60), COV: 97.66 (+3.05)

Medtronic Earnings In Line; Sales Guidance Up
at Investor's Business Daily - 36 mins ago
Medical-device giant Medtronic (MDT) early Tuesday delivered a solid quarter and modestly bullish revenue guidance as it digests several small acquisitions and prepares for a huge one. Medtronic was up 3.5% in early trading in the stock market today,...
MDT: 71.79 (+2.60), COV: 97.66 (+3.05), STJ: 65.18 (+0.01)

Early Glance: Medical Devices companies
AP - 1 hr 8 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 111.63 (+0.95), JNJ: 109.01 (+0.71), MDT: 71.79 (+2.60), BAX: 72.21 (+0.21)

Advanced Remote Patient Monitoring Systems Market Report: 2014 Edition
M2 - 1 hr 12 mins ago
Research and Markets (http://www.researchandmarkets.com/research/f348f9/advanced_remote) has announced the addition of the "Advanced Remote Patient Monitoring Systems, 7th Edition" report to their offering. For their potential to reduce healthcare costs and improve patient outcomes, patient monitoring systems with advanced capabilities are among the fastest-growing devices in terms of revenue growth. In recent years, there's been demand from healthcare organizations for monitors with remote reporting functions and EMR transfer. Advanced Remote Patient Monitoring Systems, is a comprehensive study on the patient monitoring industry, including the advanced system with remote and wireless capability to includes patient monitoring equipment and devices which have advanced features. The report specifically focuses on technologically advanced (including wireless and remote) patient monitors; monitors with patient data processing applications; and monitors which are capable of data transfer to an EMR system-including equipment and peripherals which coordinate the flow of data to hospital electronic medical record systems. For the most part, devices covered in this report can: 1) provide monitoring information beyond a patient room; and 2) provide data for an EMR system or are expected to add such features within the forecast period. This report provides complete market sizes and revenue breakouts for the important segments of the advanced monitoring market. For the purpose of this report, three general areas of advanced patient monitoring are covered. - Blood Management and Function Monitors - Glucose Monitor, Blood Pressure Monitor, PT/INR, Other - Cardiac Event and Function Monitors - Cardiac Event, EKG/ECG - Neurological Event Monitors - Respiratory Function Monitors - Anesthesia - General - Sleep Apnea There are a considerable number of companies offering some form of wireless and remote technologies, patient data processing applications and equipment, and EMR data transfer equipment. A select few are profiled in this report including: - Abbott Laboratories - Aerotel Medical Systems - Alere - AMD Global Telemedicine - American TeleCare - AuthentiDate - B. Braun - Baxter - Bosch - Boston Scientific - C.R. Bard - Cardiocom - Carematix - Compumedics . - Covidien - Criticare Systems - Dr?ger Medical - GE Healthcare - Masimo - MEDTRONIC - Mindray - Omron Healthcare - OSI Systems - PHILIPS HEALTHCARE - Roche - Schiller - Second Opinion Telemedicine . - Smiths Medical - St. Jude Medical - Welch Allyn For more information visit http://www.researchandmarkets.com/research/f3...ced_remote
CMD: 71.58 (+0.41), BSX: 13.46 (+0.08), ABT: 43.61 (-0.10), MDT: 71.79 (+2.60), STJ: 65.18 (+0.01), OSIS: 68.67 (+0.23)

Unusual Social Activity Today Around Medtronic (MDT)
at The Street - 1 hr 16 mins ago
Trade-Ideas LLC identified Medtronic (MDT) as an unusual social activity candidate
MDT: 71.79 (+2.60)

MediPoint: Aortic Stent Grafts - Current and Future Players
M2 - 1 hr 54 mins ago
Research and Markets (http://www.researchandmarkets.com/research/pk7mdq/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - Current and Future Players" report to their offering. The report identifies and analyzes the key companies shaping and driving the Aortic Stent Grafts market. The report provides insight into the competitive Aortic Stent Grafts landscape, including new companies entering the market and pipeline products in development. Scope - Investigation of current and future market competition for Aortic Stent Grafts. - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Aortic Stent Grafts in clinical practice. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Competitive Assessment 4 Pipeline Assessment 5 Current and Future Players 6 Appendix Companies Mentioned - Altura Medical - Aptus Endosystems - B. Braun - Bolton Medical - Braile Biom?dica - Cardiatis - Cook Medical - Endologix - Getinge Group - Gore Medical - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - LeMaitre Vascular - Lifetech Scientific - Lombard Medical - Medtronic - MicroPort Scientific Corporation - Nano Endoluminal - Terumo Corporation - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/pk...int_aortic
JNJ: 109.01 (+0.71), MDT: 71.77 (+2.58), EVAR: 6.50 (-0.06), LMAT: 7.27 (+0.17)

Medtronic earnings off 7% in FQ2
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 7:07AM CST

MDT: 71.77 (+2.58)

Medtronic (MDT) Q2 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 18, 6:55AM CST

MDT: 71.77 (+2.58)

Medtronic EPS and revenue in-line
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 6:43AM CST

MDT: 71.76 (+2.57)

Medtronic meets 2Q profit forecasts
Automated Insights - Tue Nov 18, 6:24AM CST
MINNEAPOLIS (AP) _ Medtronic Inc. (MDT) on Tuesday reported earnings of $828 million in its fiscal second quarter.
MDT: 71.76 (+2.57)

Medtronic Reports Second Quarter Earnings
Thomson Reuters ONE - Tue Nov 18, 6:15AM CST
- Revenue of $4.4 Billion Grew 5% on Constant Currency Basis; 4% as Reported
MDT: 71.76 (+2.57)

MiMedx's Competitive Advantage And Management Execution Charts Path To Future Growth And Shareholder Opportunity
Dave Kelly - at Seeking Alpha - Tue Nov 18, 5:45AM CST

ZMH: 111.63 (+0.95), MDT: 71.76 (+2.57), MDXG: 10.69 (+0.45)

Final Glance: Medical Devices companies
AP - Mon Nov 17, 5:02PM CST
NEW YORK (AP) — Shares of some top medical devices companies were up at the close of trading:
ZMH: 111.63 (+0.95), JNJ: 109.01 (+0.71), MDT: 71.76 (+2.57), BAX: 72.22 (+0.22)

Notable earnings before Tuesday's open
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 4:30PM CST

HD: 96.67 (-1.36), JASO: 8.20 (+0.40), TJX: 60.17 (-1.37), MDT: 71.76 (+2.57), VVTV: 5.89 (+0.31), DKS: 47.19 (-0.32), MANU: 16.67 (+0.38), CYRN: 1.64 (+0.16)

Midday Glance: Medical Devices companies
AP - Mon Nov 17, 1:22PM CST
NEW YORK (AP) — Shares of some top medical devices companies are up at 1 p.m.:
ZMH: 111.63 (+0.95), JNJ: 109.01 (+0.71), MDT: 71.76 (+2.57), BAX: 72.22 (+0.22)

Medtronic and Covidien Shareholder Meetings Scheduled for January 6, 2015
Thomson Reuters ONE - Mon Nov 17, 11:30AM CST

MDT: 71.76 (+2.57), COV: 97.65 (+3.04)

Cal INDEX Expands and Strengthens Senior Management Team with Appointment of Four Healthcare Technology Industry Veterans
Business Wire - Mon Nov 17, 10:30AM CST
The California Integrated Data Exchange (Cal INDEX) today announced the appointment of four new members to its senior management team. Greg LeClaire joins as chief financial officer from Aetna Inc.'s Healthagen division, where he served as chief financial officer for three companies, including Medicity, Inc., HDMS, Inc. and Population Health IT. John Lee joins as chief technology officer from Oracle Corporation, where he served as vice president of product development. Andrea Leeb, R.N., Esq., CIPP-US, joins as chief privacy officer following her position as assistant managing counsel for L.A. Care Health Plan in Los Angeles, the nation's largest publicly operated health plan serving more than 1.6 million members. And Doug Hart joins as vice president of marketing and corporate communications from ConvergeHEALTH by Deloitte, where he served as vice president of marketing.
MDT: 71.76 (+2.57), AET: 87.38 (+1.16), ORCL: 41.37 (+0.21)

DexCom Still A Favorite Diabetes Stock
Bill Gunderson - at Seeking Alpha - Mon Nov 17, 10:15AM CST
DexCom (NASDAQ: DXCM ) continues to be one of my favorite diabetes stocks. DexCom, founded in 1999 and based right here in my hometown of San Diego, California, is a medical device company that makes continuous glucose monitoring (CGM) systems. ...
JNJ: 109.01 (+0.71), ABT: 43.61 (-0.10), DXCM: 51.73 (-0.01), MDT: 71.76 (+2.57)

What To Expect When Medtronic (MDT) Reports Its Fiscal Second Quarter Results Tuesday
at The Street - Mon Nov 17, 9:59AM CST
Medtronic (MDT) will report its fiscal second quarter earnings results before the opening bell on Tuesday.
MDT: 71.76 (+2.57)

Medtronic, Inc. (MDT) Stock Research Links

MDT Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Caldolor®: A Breakthrough in Opioid-Sparing Pain Relief for Seniors

Updated Category News Views 183

Revolutionizing Pain Management for Older Adults This comprehensive analysis reveals groundbreaking findings about Caldolor® (intravenous ibuprofen) and its effectiveness in managing pain for older adults. As the population ages, the need for safer alternatives for pain relief has significantly increased. Recent studies showcase a marked reduction in opioid consumption...

Continue Reading
Certara Stock Faces Challenges as it Hits a 52-Week Low

Updated Category News Views 120

Certara's Stock Market Performance Certara Inc. (NASDAQ: CERT), recognized as a frontrunner in biosimulation technology, has recently seen its stock price fall to a concerning 52-week low of $10.35. This price decline highlights a notable shift from its previous valuation, indicating a tumultuous time for shareholders. Over the last year, Certara's stock has experienced a...

Continue Reading
Urgent Reminder for WM Technology Shareholders on Lead Plaintiff Deadline

Updated Category News Views 159

Important Information for WM Technology Shareholders The Gross Law Firm is reaching out to shareholders of WM Technology, Inc. (NASDAQ: MAPS). This notice serves as a crucial reminder regarding the upcoming deadline for appointing a lead plaintiff in the class action lawsuit involving the company. Who Should Contact the Gross Law Firm? If you have purchased shares of MAPS...

Continue Reading
Nebraska Medicine Enhances Cancer Services with Expansion

Updated Category News Views 82

Nebraska Medicine Strengthens Cancer Care Network Nebraska Medicine is making significant strides in enhancing cancer care with the introduction of its new facility, Nebraska Medicine Fred & Pamela Buffett Cancer Center – Kearney. This expansion aims to serve communities across various regions, and it heralds an exciting phase for cancer treatment and research in the...

Continue Reading
Sunshine Silver's IPO: A Spotlight on Silver's Future

Updated Category News Views 8

Sunshine Silver Steps into the Spotlight Ah, the thrill of a fresh IPO. Sunshine Silver Mining & Refining Company, rolling under the ticker SSMR, has announced its initial public offering price—$13.50 a share, with 20 million shares up for grabs. This development has sure piqued the interest of traders eyeing some silver lining. The Figures That Matter Alright, let’s...

Continue Reading